4 ms·
A more skeptical take. http://blogs.sciencemag.org/pipeline/archives/2017/01/11/12110 http://blogs.sciencemag.org/pipeline/archives/2017/01/11/121... Tl;dr Alz
by jamesash 10y ago
A more skeptical take. http://blogs.sciencemag.org/pipeline/archives/2017/01/11/12110 http://blogs.sciencemag.org/pipeline/archives/2017/01/11/121...
Tl;dr Alzheimer's is hard to drug, and the approach this company is trying has been tried before.
- kgwgk 10y agoSee also https://www.thestreet.com/story/13178707/1/inside-the-hedge-fund-club-pitching-a-new-alzheimers-drug-ipo.html https://www.thestreet.com/story/13178707/1/inside-the-hedge-... The plan is simple. You fund a company and spend $5mn acquiring the rights to a drug that might be worth billions (not very likely, if you can get it at that price). And before investing your own money to find out, you sell one fourth of that company for $360mn because "Hey, it could be worth billions!!!!"
- 55555 10y agoWho on earth bought into that IPO? Who priced it? Did they really just spend 5mm on rights to a drug, put it in a shell company, and then convince the public via IPO that it was worth 1.3+ billion? This sounds like a pump and dump or money extraction scheme. I imagine it was mostly sold to pensions, etc.
- deleted 10y ago[deleted]